Accessibility settings

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/92647, first published .
Person in VR headset rests in armchair; tablet, vial, and syringe on table.

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study

Acacia C Parks   1 , MBA, PhD ;   Amanda L Woodward   1 , MSc ;   Robert D Henry   2, 3 , PhD ;   Kristin A Arden   4 , APRN, PMHNP-BC, DNP ;   Leonardo Vando   4 , MD ;   Jack Swain   4 , MBA ;   Bishal Lamichhane   5 , PhD

1 Liquid Amber, Watertown, MA, United States

2 TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Tulsa, OK, United States

3 Department of Biostatistics & Epidemiology, University of Oklahoma Health Sciences Center, Tulsa, OK, United States

4 Mindbloom, Orlando, FL, United States

5 Department of Psychiatry and Behavioral Health, Houston Methodist Academic Institute (HMAI), Houston Methodist, Houston, TX, United States

Corresponding Author: